| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
27,480,000 |
| Market
Cap: |
48.36(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.29 - $2.27 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Synthetics |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Dyadic International is a global biotechnology platform company and it utilizes a number of third-party consultants and research organizations to carry out its activities. Co. has developed a gene expression platform for producing commercial quantities of enzymes and other proteins. This technology is based on the Thermothelomyces heterothallica fungus, which Co. named C1. The C1-cell protein production platform is a versatile thermophilic filamentous fungal expression system for the development and production of biologic products including enzymes and other proteins.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
8,943 |
| Total Sell Value |
$0 |
$0 |
$0 |
$31,202 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-10-10 |
4 |
AS |
$6.04 |
$28,883 |
D/D |
(4,782) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-10-10 |
4 |
OE |
$1.41 |
$6,743 |
D/D |
4,782 |
4,782 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-09-10 |
4 |
AS |
$5.27 |
$52,700 |
D/D |
(10,000) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-09-10 |
4 |
OE |
$1.41 |
$14,100 |
D/D |
10,000 |
10,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-08-13 |
4 |
AS |
$5.75 |
$36,225 |
D/D |
(6,300) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-08-13 |
4 |
OE |
$1.41 |
$8,883 |
D/D |
6,300 |
6,300 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-08-12 |
4 |
AS |
$5.72 |
$21,164 |
D/D |
(3,700) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-08-12 |
4 |
OE |
$1.41 |
$5,217 |
D/D |
3,700 |
3,700 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-07-10 |
4 |
AS |
$5.87 |
$58,700 |
D/D |
(10,000) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-07-10 |
4 |
OE |
$1.41 |
$14,100 |
D/D |
10,000 |
10,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-06-18 |
4 |
AS |
$6.44 |
$128,800 |
D/D |
(20,000) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-06-18 |
4 |
OE |
$1.41 |
$28,200 |
D/D |
20,000 |
20,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-06-17 |
4 |
AS |
$6.11 |
$122,200 |
D/D |
(20,000) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-06-17 |
4 |
OE |
$1.41 |
$28,200 |
D/D |
20,000 |
20,000 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2019-04-12 |
4 |
OE |
$1.71 |
$85,500 |
I/I |
50,000 |
4,166,987 |
|
- |
|
| Kitt Barry M |
10% Owner |
– – • |
2015-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,363,589 |
|
- |
|
66 Records found
|
|
Page 3 of 3 |
|
|
0.21 (10.66%) 
